OAM
COLL icon

Oxford Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Oxford Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,964
Closed -$534K – 441
2019
Q4 		$534K Sell
25,964
-31,832
-55% -$531K 0.01% 1200
2019
Q3 		$663K Buy
+57,796
New +$660K 0.02% 1141

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Oxford Asset Management's COLL Position: Q1 2020 in Review

Oxford Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2020, closing a stake of 25,964 shares — an estimated $534K sold.

Oxford Asset Management first reported a position in COLL in Q3 2019 and held it in 2 quarters. The position peaked at $663K in Q3 2019. 159 funds tracked by Wall St. Rank hold COLL as of Q1 2020.

  • Oxford Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 25,964 Collegium Pharmaceutical shares in Q1 2020, an estimated $534K.
  • Oxford Asset Management first reported a position in Collegium Pharmaceutical in Q3 2019 and held it in 2 quarters.
  • Oxford Asset Management's Collegium Pharmaceutical position peaked at $663K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.